Mark Throsby
Inventor
Stats
- 22 US patents issued
- 72 US Applications filed
- most recent filing
This is official USPTO record data
Details
- 22 US Patents Issued
- 72 US Applications Filed
- 463 Total Citation Count
- Apr 30, 2024 Most Recent Filing
- Mar 23, 2006 Earliest Filing
Work History
| Patent Owner | Applications Filed | Year |
|---|---|---|
| JANSSEN VACCINES & PREVENTION B.V. | 1
1 | 2013
2015 |
| THE JOHNS HOPKINS UNIVERSITY | 2
| 2006
|
| CRUCELL HOLLAND B.V. | 9
8 2 6 6 7 | 2006
2007 2010 2011 2012 2013 |
| MERUS BIOPHARMACEUTICALS B.V. | 2
| 2012
|
| MERUS N.V. | 1
2 3 4 1 1 | 2009
2012 2014 2015 2016 2017 |
| MERUS B.V. | 1
| 2009
|
Inventor Addresses
| Address | Duration |
|---|---|
| Utrach, NL | Apr 23, 09 - Apr 23, 09 |
| Utrecht, NL | Nov 16, 06 - Mar 11, 25 |
| Utrecht, Utrecht, NL | May 21, 09 - May 21, 09 |
Technology Profile
| Technology | Matters | |
|---|---|---|
| A01K: | ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS | 11 |
| A61K: | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | 34 |
| A61P: | THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS | 22 |
Patents / Publication
| Patents / Publication # | Year of Publication / Issued | Title | Citations |
|---|---|---|---|
| 12247078 | 2025 | ERBB-2 and ERBB-3 binding bispecific antibodies for use in the treatment of cells that have an NRG1 fusion gene | 0 |
| 12139548 | 2024 | Antibody that binds ErbB-2 and ErbB-3 | 0 |
| 2024/0343,824 | 2024 | BINDING MOLECULES THAT INHIBIT CANCER GROWTH | 0 |
| 12091461 | 2024 | Bispecific antibody | 0 |
| 2024/0287,187 | 2024 | BISPECIFIC ANTIBODY | 0 |
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level.
>
Upgrade to our Level for up to -1 portfolios!.